Navigation Links
Malignant virus in polio vaccine combined to Cancer

Researchers have found traces of a monkey virus that contaminated the polio vaccine in the early 50's in a common form of highly malignant human cancer that has mystically doubled in incidence over the past 30 years. Two studies, found a link between the virus, called SV40, and non-Hodgkin lymphomas, a disorder ranked fourth or fifth among cancer deaths in the United States among women and men, respectively. //

Results suggest that the virus may play a much wider role in cancer than previously suspected. Dr. Janet Butel, a lead researcher of the study at Bayor College, No obvious risk factors have emerged for non-Hodgkin lymphoma in the general population, but a viral cause has been postulated,'' said a group of eight researchers at Baylor College of Medicine in Texas led by Dr. Janet Butel. ``This finding sheds new light on the possible genesis of (this) important group of malignant disorders.''

The scientists added that their findings may also offer hope for new therapies for the malignancies. The Salk polio vaccine, administered by injection in the United States and worldwide from 1950 through 1960, was grown on minced kidney tissue from rhesus monkeys.

At the time, the manufacturing process was considered safe. But in 1960, it was discovered that large batches of the vaccine were contaminated with the simian virus later named SV40. An estimated 90 million Americans received Salk vaccine injections and as many as 30 million were exposed to the virus.

In laboratory tests, hamsters injected with SV40 developed a variety of malignant tumors, but early government studies indicated that the virus appeared to have no negative effect in humans who had been exposed. That view began to change in the 1990s when DNA detection techniques became much more refined and evidence of the virus started showing up in human tumors. The group included rare brain, bone and lung-related cancers called mesotheliomas.

Other resear ch has also turned up SV40 in tumors of children and adults born after the contaminated vaccine was taken off the market in 1963, leading to the still-unsolved mystery of how the virus is being transmitted. Friday's reports indicate that SV40 may be involved in a much broader group of human cancers, playing a possible role in nearly half of the 50,000 new cases of non- Hodgkin lymphoma diagnosed annually.

The cancer, which can be highly aggressive, has been associated with HIV-positive patients, and it was thought that the suppression of the immune system in these patients may have had a connection with the dramatic increase in lymphomas since 1970.

The new studies examined lymphomas from HIV-positive and -negative patients. Results suggested that both groups had either about the same level of SV40 DNA fragments, or that the HIV- negative samples had a greater incidence.

The second group of researchers were at the Fred Hutchinson Cancer Research Center in Seattle and the University of Texas Southwestern Medical Center in Dallas. Remarkably, both groups of researchers using slightly different detection techniques came up with almost identical results: SV40 fragments were found in 42 percent of 154 lymphomas sampled in one study, while the other found 43 percent in 68 cases.

No virus was detected by either study in nonmalignant lymphoid samples and other cancers used as controls. A Chronicle investigation reported last year that there is a heated controversy surrounding detection of SV40 and that most U.S. government's studies over the past decade have debunked the theory that SV40 is causing human cancer or even present in tumors.

But The Chronicle found that more than 60 studies from 30 laboratories around the world have reported detections of the virus in human malignancies. Dr. Jay A. Levy, a renowned virologist ``I've been in meetings where people say there is nothing to it,'' said at the University of Californ ia at San Francisco. ``That attitude is wrong.''

Levy said he had carefully reviewed the papers published Friday and was impressed with the research. ``You just can't walk away from it,'' he said, noting that the association found was very strong. ``But there is still quite a difference between association and causation,'' he added, ``and proving causation is very difficult.''

Dr. Adi Gazdar of the University of Texas, who led the second study, said yesterday that the ``data is very, very solid.'' He said it had to be more than coincidence that the four types of tumors found in hamsters after injection with SV40 - brain, bone, mesothelioma and lymphomas - are now exactly the same tumor types in humans found with detectable levels of SV40.

``The chances are 10 million to 1 it is a coincidence,'' he said. Evidence of how the virus works in tumors is growing as research shows that proteins from SV40 have a powerful effect in turning off tumor suppressor genes in humans.

Gazdar and the other researchers said that the recent SV40 discoveries also could help lead to effective cancer treatment, by using SV40 as a target for therapies. ``A vaccine targeting SV40 in mesothelioma is now being developed,'' he said. ``But it's still only a potential therapy, and we don't know if it will work yet.''

He said that U.S. officials have all but ignored the SV40 detections and that government funding and support for research has been nonexistent. One reason given by Gazdar and other scientists is that the government is worried about its role in promoting polio vaccination campaigns in the 1950s.

Jackie Kennedy And maybe it's because the first SV40-related cancers that were discovered were such rare ones,'' Gazdar said. ``But you can't ignore lymphoma; it's too widespread and too important a cancer. Jackie Kennedy and a lot of other well- known people have died from it.''


'"/>




Related medicine news :

1. Malignant Mesothelioma – A New Genetic Revelatio
2. Malignant Mesothelioma – A New Genetic Revelation
3. Experimental Therapy Effective Against Malignant Melanoma in Horses
4. Protein Involved In Embryo Formation Found In Malignant Cells
5. Novel Suicide Gene Therapy Used to Treat Malignant Brain Tumors
6. Detection of Malignant Breast Tumors Made Simpler and More Effective
7. Minor mutations in HIV virus
8. Infertility in relation with virus
9. Birds breed viruses
10. Hidden influenza virus protein found
11. Hepatitis E virus made impotent
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... 2016 , ... This campaign aims to provide a path to improved education ... control and change. , As nearly 795,000 Americans suffering from a new or recurrent ... Plus, with an estimated 129,000 of these people dying from stroke, it’s become our ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... Mediaplanet to help educate the many who are unaware of the plight of ... aphasia will run within the “Stroke Awareness” campaign. , The link between stroke ...
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in ... courtesy of leaders in the nursing and health care industry. It also provides ... and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is adding ...
(Date:5/27/2016)... ... May 27, 2016 , ... Each year Standard ... Allison Outerbridge is this year’s Life University winner of a $2,500 ... university’s Student Leadership Awards ceremony. , Outerbridge is approaching her last quarter at ...
(Date:5/26/2016)... ... , ... Despite last week’s media reports hinting at a June rate hike ... March 2017 for an interest rate increase, according to Rajeev Dhawan of the Economic ... Federal Open Market Committee (FOMC) dot charts are of interest to the press for ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
(Date:5/26/2016)... May 26, 2016   Change Healthcare ... analytics, network solutions and technology-enabled services designed ... entered into a strategic channel partnership with ... software solutions and revenue cycle management services ... and rehabilitation clinics to optimize revenue, operational ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, 2016 ... ; Frankfurt Prime Standard: QIA) today announced that the company ... Diagnostics GmbH to develop and commercialize predictive assays in oncology. ... as a marker to predict effectiveness of anthracycline treatment in ... "We are pleased to partner with Therawis, which developed the ...
Breaking Medicine Technology: